These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 3237234)

  • 21. Expression of Bcl-2 in dysplastic and neoplastic cervical lesions in relation to cell proliferation and HPV infection.
    Brychtová S; Brychta T; Kotrsová L; Pilka R; Tichý M; Tichá V; Kolár Z
    Neoplasma; 2000; 47(3):143-7. PubMed ID: 11043835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytologic screening for cancer of the uterine cervix. "The debate of 1980s".
    Yoonessi M; Yip J; Sullivan A
    Diagn Gynecol Obstet; 1981; 3(1):5-8. PubMed ID: 7215125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-mediated cytotoxicity in preinvasive and invasive squamous cell carcinoma of the cervix.
    Dini MM; Jafari K; Faiferman I
    Obstet Gynecol; 1980 Jun; 55(6):728-31. PubMed ID: 7383460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of epithelial-specific antigen in uterine cervix with endocervical glandular dysplasia.
    Umezaki K; Sanezumi M; Okada H; Okamura A; Tsubra A; Kanazaki H
    Gynecol Oncol; 1997 Sep; 66(3):393-8. PubMed ID: 9299251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of the ThinPrep monolayer technique and conventional cervical Pap smears in a high-risk population using the Munich II nomenclature].
    Lellé RJ; Cordes A; Regidor M; Maier E; Flenker H
    Gynakol Geburtshilfliche Rundsch; 2007; 47(2):81-7. PubMed ID: 17440269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of a cytologic diagnosis of atypical glandular cells of undetermined significance.
    Cheng RF; Hernandez E; Anderson LL; Heller PB; Shank R
    J Reprod Med; 1999 Nov; 44(11):922-8. PubMed ID: 10589401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytologic evidence of the association of condylomatous lesions with dysplastic and neoplastic changes in the uterine cervix.
    Syrjänen KJ; Heinonen UM; Kauraniemi T
    Acta Cytol; 1981; 25(1):17-22. PubMed ID: 6937062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of cervical disease history on outcomes of women who have a pap diagnosis of atypical glandular cells of undetermined significance.
    Raab SS; Bishop NS; Zaleski MS
    Gynecol Oncol; 1999 Sep; 74(3):460-4. PubMed ID: 10479510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytomorphometric differences among individual "moderate dysplasia" cells derived from cervical intraepithelial neoplasia.
    Rosenthal DL; Suffin SC; Missirlian N; McLatchie C; Castleman KR
    Anal Quant Cytol; 1984 Sep; 6(3):189-95. PubMed ID: 6508036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silver-stained nucleolar organizer regions in normal and dysplastic cervical lesions: correlation with DNA ploidy and S-phase fraction by flow cytometry.
    Singh M; Prasad S; Kalra N; Singh U; Shukla Y
    Oncology; 2006; 71(5-6):411-6. PubMed ID: 17785995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignancy associated changes in cervical smears: systematic changes in cytometric features with the grade of dysplasia.
    Guillaud M; Doudkine A; Garner D; MacAulay C; Palcic B
    Anal Cell Pathol; 1995 Oct; 9(3):191-204. PubMed ID: 8562458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A, B & H isoantigens in cervical lesions.
    Bisht D; Misra V; Gupta SC; Mehrotra R; Garg S
    Indian J Pathol Microbiol; 1998 Jan; 41(1):11-4. PubMed ID: 9581070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depression of high-affinity rosette formation in dysplasia and carcinoma in situ of the uterine cervix: mediation by serum factors.
    Bashford J; Gough IR
    Cancer Res; 1983 Aug; 43(8):3959-62. PubMed ID: 6861159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infrared microspectroscopy and artificial neural networks in the diagnosis of cervical cancer.
    Romeo M; Burden F; Quinn M; Wood B; McNaughton D
    Cell Mol Biol (Noisy-le-grand); 1998 Feb; 44(1):179-87. PubMed ID: 9551649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Is the end of the Pap classification in sight?].
    Boon ME; Bosch MM
    Ned Tijdschr Geneeskd; 1990 May; 134(20):1016-8. PubMed ID: 2348893
    [No Abstract]   [Full Text] [Related]  

  • 36. Phagocytic activity of circulating polymorphonuclear leukocytes from patients with carcinoma of the uterine cervix.
    García-González JE; Rojas-Espinosa O; Aguilar-Santelises M
    Rev Latinoam Microbiol; 1992; 34(2):135-41. PubMed ID: 1345310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-mediated immunity to encephalitogenic factor (MMI test) in women with cervical dysplasia and carcinoma in situ: the effects of serum.
    Flavell DJ; Singer A; Potter CW
    Br J Cancer; 1978 Sep; 38(3):396-400. PubMed ID: 81675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer cell activity in patients with abnormalities of the uterine cervix.
    Neill W; Norval M
    Gynecol Obstet Invest; 1984; 18(3):122-8. PubMed ID: 6092242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apoptotic effect of a novel kefir product, PFT, on multidrug-resistant myeloid leukemia cells via a hole-piercing mechanism.
    Ghoneum M; Gimzewski J
    Int J Oncol; 2014 Mar; 44(3):830-7. PubMed ID: 24430613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nano-hole induction by nanodiamond and nanoplatinum liquid, DPV576, reverses multidrug resistance in human myeloid leukemia (HL60/AR).
    Ghoneum A; Sharma S; Gimzewski J
    Int J Nanomedicine; 2013; 8():2567-73. PubMed ID: 23888112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.